EPZ-031686

N/A

Report date: 2024/11/28 15:05:19

NME

Base Information

Drug NameEPZ-031686

Drug Alias NameEPZ-031686

ClassificationSmall molecules > Heterocyclic drugs

Mechanisms of ActionHistone-lysine N-methyltransferase SMYD3 inhibitors

TargetsHistone-lysine N-methyltransferase SMYD3

Therapy Area/IndicationsNeoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryN/A

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesEpizyme Inc

China Registration ClassN/A

Active CompaniesEpizyme Inc

Inactive CompaniesN/A

Active IndicationsNeoplasms

Inactive IndicationsN/A

ATC CodeN/A